Hengkang Medical Group Co., Ltd.

Sümbol: 002219.SZ

SHZ

2.47

CNY

Turuhind täna

249.1204
P/E suhe
78.8881
PEG suhe
8.42B
MRK Cap
0.00%
DIV tootlus

Hengkang Medical Group Co., Ltd. (002219-SZ) Finantsaruanded

Q: Mis on Hengkang Medical Group Co., Ltd. (002219.SZ) koguvara?

Hengkang Medical Group Co., Ltd. (002219.SZ) koguvara on .

Q: Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on .

Download

Aastane Quarterly

Lineaarne Log

Diagrammil näete Hengkang Medical Group Co., Ltd. (002219.SZ) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist 1504.937 M, mis on 0.210 % gowth. Kogu perioodi keskmine brutokasum on 487.374 M, mis on 0.212 %. Keskmine brutokasumi suhtarv on 0.442 %. Ettevõtte eelmise aasta tulemuse puhaskasv on -0.803 %, mis on võrdne -0.884 % % keskmiselt kogu ettevõtte ajaloo jooksul.,

Aastane Quarterly

10Y 20Y 30Y 40Y

Bilanss

Sukeldudes Hengkang Medical Group Co., Ltd. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja 0. Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus 0.078. Käibevara valdkonnas on 002219.SZ aruandlusvaluutas 1956.009. Märkimisväärne osa neist varadest, täpsemalt 580.235, hoitakse sularahas ja lühiajalistes investeeringutes. See segment näitab eelmise aasta andmetega võrreldes muutust 0.038%. Ettevõtte pikaajalised investeeringud, kuigi need ei ole tema fookuses, seisavad 6.87, kui neid on, aruandlusvaluutas. See näitab erinevust 16.493% võrreldes eelmise aruandeperioodiga, mis kajastab ettevõtte strateegilisi muutusi. Ettevõtte võlaprofiil näitab, et ettevõtte pikaajaline koguvõlg on 722.244 aruandlusvaluutas. See näitaja tähendab, et aastane muutus on 0.299%. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud 2195.689 aruandlusvaluutas. Selle aspekti aastane muutus on 0.274%. Kui süveneda ettevõtte finantsnäitajatesse, ilmneb täiendavaid üksikasju. Netovõlad on hinnatud 1121.511, varude hind on 218.55 ja firmaväärtus 949.01, kui see on olemas. Kogu immateriaalne vara, kui see on olemas, hinnatakse 304.41. Kontovõlad ja lühiajalised võlad on vastavalt 1299.58 ja 1168.71. Koguvõlg on 2056.89, netovõlg on 1476.66. Muud lühiajalised kohustused moodustavad 373.94, mis lisandub kohustuste kogusummale 3842.82. Lõpuks hinnatakse viidatud aktsia 0, kui see on olemas.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004
balance-sheet.row.cash-and-short-term-investments	2320.73	580.2	558.9	2033.2	171.7	122.3	347.3	594.4	705.4	1015.3	193.4	110.8	300.7	212.6	112	88.3	110.8	60.8	33.5	11.1	5.9
balance-sheet.row.short-term-investments	-129.17	0	0	-66.5	-51.5	-52.3	-72.1	-67.4	-19.7	-13.3	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.net-receivables	4854.98	1121.5	1056.1	784.2	838.7	861.8	1624.7	1966.2	1692.4	1002.9	852.8	325.3	172.1	138.2	128.7	119.3	146.2	51.5	42.3	35.9	50.2
balance-sheet.row.inventory	838.46	218.5	164.4	185.3	178.3	154.8	308.5	845.3	528.9	124.6	99	100.3	97.4	95.5	93.5	75.4	34.6	81.9	84.8	81.1	66.9
balance-sheet.row.other-current-assets	84.61	35.7	17.9	21.2	10.3	2.5	16.5	38.9	3.3	80	-222.8	-46.8	-18.7	-14.1	-10.3	-5.8	-13.3	-1.8	-8.9	-9.5	-11.9
balance-sheet.row.total-current-assets	8098.77	1956	1797.3	3023.8	1199	1141.4	2297	3444.8	2930	2222.8	922.3	489.7	551.5	432.2	324.1	277.1	278.3	192.4	151.7	118.7	111.2
balance-sheet.row.property-plant-equipment-net	10328.04	2638.3	2470	2308.8	2186.6	2272	2509.6	2577.6	1699.6	1372	285.7	223.8	173.8	146.5	165.5	154.4	70.8	42.7	34.4	37.8	41
balance-sheet.row.goodwill	3731.36	949	884.1	884.1	986.7	986.7	3192.7	3529	973.8	900.6	323.7	189.3	16.5	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	1169.52	304.4	265.6	274	270.6	300.4	466.8	474.7	267.7	231.5	208.5	219	106.7	10.5	10.8	6.3	6.5	0.8	0.8	0.8	0.8
balance-sheet.row.goodwill-and-intangible-assets	4900.88	1253.4	1149.7	1158.1	1257.3	1287.1	3659.6	4003.7	1241.6	1132.1	532.1	408.2	123.2	10.5	10.8	6.3	6.5	0.8	0.8	0.8	0.8
balance-sheet.row.long-term-investments	155.91	6.9	5.9	72.6	63.7	63.6	77.9	75.1	22.5	13.8	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	643.59	160.4	141.2	126.2	106.2	123.7	162.8	106.4	56.8	39.6	13.4	11.7	12.3	2	1.9	2.1	1.2	0.4	0.4	0.3	0
balance-sheet.row.other-non-current-assets	205.88	65.2	78	0.7	8	22.1	52.1	45.7	34.3	0	137.8	9.7	8.3	9.6	11.1	12.6	2.1	0	0	0	0
balance-sheet.row.total-non-current-assets	16234.3	4124.2	3844.8	3666.4	3621.8	3768.5	6462	6808.4	3054.8	2557.5	969	653.4	317.6	168.6	189.3	175.3	80.6	44	35.6	38.9	41.8
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	24333.07	6080.2	5642.1	6690.2	4820.8	4909.9	8759	10253.2	5984.7	4780.3	1891.4	1143.1	869.1	600.8	513.4	452.4	358.9	236.4	187.3	157.7	153
balance-sheet.row.account-payables	5233.56	1299.6	1161.3	1000.4	874.8	831.2	628.4	584	343.3	187.4	66.6	48.3	33.5	16.4	27.3	32.3	21.2	32.5	26.7	26.8	17
balance-sheet.row.short-term-debt	3965.62	1168.7	1127.7	2103.6	2136.3	2549.3	1544.2	2835.6	899.9	132.6	476.8	151	190	50	20	30	0	45	26.6	10	24
balance-sheet.row.tax-payables	119.33	13.8	60.1	53.2	53.1	19.2	36.6	53	39.7	87	57	50	44.9	48.1	39.2	24.2	15	10	8.4	7.8	1.3
balance-sheet.row.long-term-debt-total	3055.43	722.2	456.2	335.3	290	300	1588.8	503.6	10	32.6	1.3	2	3.3	0	0	0	0	0	0	2	2
Deferred Revenue Non Current	9.33	2.9	2.1	2.1	8.7	95.1	4.9	7.7	3.7	1.3	0	1.2	1.2	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	158.59	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	573.29	373.9	968.4	59.5	51.7	55.2	755.6	40.4	31.1	23	5.9	4	3.8	2	1.7	0.3	20.5	0.2	2.3	1	36.6
balance-sheet.row.total-non-current-liabilities	3609.48	919.5	552.7	545.8	574.7	520	2936.6	1813.9	119	109.8	20.6	21.3	25	3.9	4.8	6.4	5.2	0.5	0	2	2
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	341.92	165.9	45.7	55.3	68.7	91.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	15514.97	3842.8	3876.7	5104.2	4663	4702.4	5901.3	5905.6	1812.1	977.4	836.1	322.3	308.4	123.6	99.2	97.9	46.9	93.7	78.4	68	80.9
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	13585.04	3410.8	3264.2	1865.2	1865.2	1865.2	1865.2	1865.2	1865.2	1891.3	616.3	440.5	429.6	373.6	298.9	186.8	93.4	70	70	50	50
balance-sheet.row.retained-earnings	-12196.33	-3062	-3093.4	-3249	-2877.6	-2825.3	-305.8	1112.1	909.2	571.8	251.9	222.5	69	65.5	69.5	72.5	81.4	41.3	10.9	33.7	18.8
balance-sheet.row.accumulated-other-comprehensive-income-loss	4004.15	129.2	129.5	129.5	129.5	129.5	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	3262.4	1717.7	1422.9	2807.4	1016.7	1025.4	1151.7	1211.3	1310.5	1263.9	153	140.2	45.8	38	45.8	95.3	137.2	31.4	28	6	3.3
balance-sheet.row.total-stockholders-equity	8655.26	2195.7	1723.1	1553.1	133.8	194.8	2711.1	4188.5	4085	3727	1021.2	803.1	544.5	477.2	414.2	354.6	312	142.7	108.9	89.7	72.1
balance-sheet.row.total-liabilities-and-stockholders-equity	24333.07	6080.2	5642.1	6690.2	4820.8	4909.9	8759	10253.2	5984.7	4780.3	1891.4	1143.1	869.1	600.8	513.4	452.4	358.9	236.4	187.3	157.7	153
balance-sheet.row.minority-interest	159.97	38.8	42.2	33	24	12.7	146.5	159.1	87.7	75.9	34.2	17.7	16.2	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	8815.23	2234.5	1765.4	1586.1	157.8	207.5	2857.7	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	24333.07	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	26.73	6.9	5.9	6.1	12.2	11.2	5.8	7.6	2.8	0.5	127.8	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-debt	7186.99	2056.9	1583.9	2438.9	2426.3	2849.3	3133	3339.2	909.9	132.6	476.8	151	190	50	20	30	0	45	26.6	12	26
balance-sheet.row.net-debt	4866.36	1476.7	1024.9	405.8	2254.6	2727	2785.7	2744.9	204.5	-882.7	283.4	40.2	-110.7	-162.6	-92	-58.3	-110.8	-15.8	-6.9	0.9	20.1

Rahavoogude aruanne

Hengkang Medical Group Co., Ltd. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab 1.067 nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides 0, mis tähistab 4.491 erinevust võrreldes eelmise aastaga. Huvitav on see, et osa ettevõtte aktsiatest, täpsemalt 0, ostis ettevõte ise tagasi. Selle tegevuse tulemusena muutus 0.000 võrreldes eelmise aastaga. Vahepeal on ettevõtte võlgnevused praegu 74.95 aruandlusvaluutas. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli -335383487.000. See on 0.744 nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte 238.65, 127, -626.4, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid 0.000, kusjuures erinevus võrreldes eelmise aastaga oli 0.000. Lisaks eraldas ettevõte -103.99 aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui -563.57, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004
cash-flows.row.net-income	33.61	30.8	164.3	-367.3	-42.5	-2497.5	-1387.7	222.7	396.2	322.1	257.1	171.3	72.9	71.3	66	47.8	44.5	33.8	19.3	17.6	13.7
cash-flows.row.depreciation-and-amortization	39.95	238.7	166.5	163.3	170.7	134.5	230.4	197.7	100.9	69.5	40.7	40.2	28.6	21.3	16.4	6.7	5.2	4.1	4.1	4	4
cash-flows.row.deferred-income-tax	35.49	-34.1	-19.4	-23.1	7.7	6.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	78.12	-650.2	19.4	23.1	-7.7	-6.8	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	-11.62	-172.9	-205.7	-28.8	32.1	364.2	497.3	-939.4	-1297	-299.5	-155.4	-95.3	-28	-2.3	-22.5	-23.9	-33.7	-7.9	-11.9	14.2	-19
cash-flows.row.account-receivables	16.16	-195.6	-160.1	-70.2	-14.1	761.4	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	-27.78	-52.3	20.8	-7.3	-23.5	67.6	360	-283.7	-400.7	-26.1	7.3	4.8	7.5	-1	-17.8	-40.4	45.7	2.8	-3.6	-14.2	-25
cash-flows.row.account-payables	0	74.9	-47	71.8	62	-471.6	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	0	-19.4	-23.1	7.7	6.8	137.3	-655.7	-896.4	-273.4	-162.8	-100.1	-35.5	-1.4	-4.6	16.5	-79.4	-10.7	-8.3	28.4	6
cash-flows.row.other-non-cash-items	205.93	879	143	510.1	123.6	2548.2	1182.6	314.2	102.6	126.9	50.9	42.2	9.1	4.5	4.6	2	6.3	1.9	2.1	0.8	1.4
cash-flows.row.net-cash-provided-by-operating-activities	264.29	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-211.07	-195.2	-221.6	-198.7	-216.6	-215.7	-220.4	-573.6	-279.6	-445.5	-25.7	-137.3	-9.1	-9.5	-28.8	-85.5	-55.7	-14.6	-0.8	-0.7	-0.3
cash-flows.row.acquisitions-net	-67.23	-139.2	49	-1	115.3	2.5	3.5	-2362	-161.7	-399.3	-248.3	-191.5	-64.8	0	0	86.2	0	0	0	0	0
cash-flows.row.purchases-of-investments	-128.1	-128.1	-122.6	-1	-0.8	-9.9	-0.6	-0.9	-320.1	-133.9	-0.9	0.2	0	0	0	-1	0	0	0	0	0
cash-flows.row.sales-maturities-of-investments	1.1	0.1	0.5	1	0.2	45.9	0	1.2	402.1	2.6	0	0.3	0	0	0	1	0	0	0	0	0
cash-flows.row.other-investing-activites	126.48	127	102.3	0.6	24.8	-98.7	-20.3	443.5	-278.3	-245	-145.7	-5	0.1	0.1	0	-85.5	4.6	-0.1	0	0	0
cash-flows.row.net-cash-used-for-investing-activites	-279.02	-335.4	-192.3	-199.1	-77.1	-276	-237.9	-2491.8	-637.5	-1221	-420.6	-333.2	-73.7	-9.4	-28.8	-84.8	-51.1	-14.8	-0.8	-0.7	-0.3
cash-flows.row.debt-repayment	-177.44	-626.4	-1063.2	-284.7	-494.6	-1535.7	-1627.9	-1033.7	-127.8	-1073.3	-281.8	-197.6	-98.3	-20	-30	0	-55	-33.8	-15.3	-39.2	-22.1
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	-19.51	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	-102.41	-104	-275.8	-54.2	-83.9	-394.9	-324.7	-199.2	-17.6	-45.1	-57.4	-14	-12.6	-14.9	-1.9	-0.6	-1	-1	-1.6	-1.5	-0.7
cash-flows.row.other-financing-activites	-59.7	-563.6	-190	2108.4	403.9	1345.1	1401.6	4245.9	748.5	2938.9	647.4	196.4	190	50	20.1	30.2	134.8	45	26.6	10	24
cash-flows.row.net-cash-used-provided-by-financing-activities	-275.2	62.8	-1529	1769.5	-174.7	-585.6	-551	3013	603.1	1820.5	308.3	-15.1	79.2	15.1	-11.8	29.6	78.8	10.2	9.7	-30.6	1.2
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	98.1	-2.8	-0.5	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	-284.06	20.9	-1453.2	1847.7	32.1	-214	-269.1	315.9	-731.8	818.5	81	-189.9	88.1	100.5	23.8	-22.6	50	27.3	22.4	5.2	1
cash-flows.row.cash-at-end-of-period	2252.92	580.2	537.9	1991.1	143.4	111.3	325.3	594.4	278.5	1010.3	191.8	110.8	300.7	212.6	112	88.3	110.8	60.8	33.5	11.1	5.9
cash-flows.row.cash-at-beginning-of-period	2536.98	559.4	1991.1	143.4	111.3	325.3	594.4	278.5	1010.3	191.8	110.8	300.7	212.6	112	88.3	110.8	60.8	33.5	11.1	5.9	4.9
cash-flows.row.operating-cash-flow	264.29	291.2	268	277.3	283.8	549.5	522.6	-204.8	-697.4	219	193.4	158.4	82.7	94.8	64.4	32.6	22.4	31.9	13.5	36.5	0.1
cash-flows.row.capital-expenditure	-211.07	-195.2	-221.6	-198.7	-216.6	-215.7	-220.4	-573.6	-279.6	-445.5	-25.7	-137.3	-9.1	-9.5	-28.8	-85.5	-55.7	-14.6	-0.8	-0.7	-0.3
cash-flows.row.free-cash-flow	53.23	96.1	46.5	78.6	67.2	333.8	302.2	-778.4	-977	-226.5	167.6	21.1	73.6	85.3	35.6	-52.9	-33.4	17.2	12.7	35.9	-0.2

Kasumiaruande rida

Hengkang Medical Group Co., Ltd. tulud muutusid võrreldes eelmise perioodiga 0.132%. 002219.SZ brutokasum on teatatud 988.6. Ettevõtte tegevuskulud on 861.84, mille muutus võrreldes eelmise aastaga on 24.652%. Kulud amortisatsioonikulud on 238.65, mis on 0.433% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud 861.84, mis näitab 24.652% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on 0, mis on 0.000% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on 0, mis tähendab -0.646% kasvu võrreldes eelmise aastaga. Tegevustulu on 126.75, mis näitab -0.646% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on -0.803%. Eelmise aasta puhaskasum oli 30.78.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012	2010	2008	2006	2004
income-statement-row.row.total-revenue	3667.58	3568.4	3152.7	3016.1	2805.9	3684.5	3838.4	3399.3	2175.2	1181.7	685.7	564.7	337	307.2	299.3	285.1	285	198.2	130.1	100.2	84
income-statement-row.row.cost-of-revenue	2599.38	2579.8	2160.1	2208.4	2015.1	2711.9	3011.8	2317.7	1392.1	628.3	274.3	174.7	126.3	107	108.9	119.1	129.3	102	80	59	45.5
income-statement-row.row.gross-profit	1068.2	988.6	992.6	807.7	790.7	972.5	826.6	1081.6	783.1	553.5	411.4	390.1	210.6	200.2	190.5	166	155.7	96.2	50.1	41.2	38.5
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	30.87	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	235.47	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	202.79	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	-12.31	-0.4	318.1	322.5	258.5	384.4	-37	7.1	32.7	72.8	32.2	3.7	11.6	9.8	6.4	3.4	7.5	2	3	2.7	0.1
income-statement-row.row.operating-expenses	875.08	861.8	691.4	721.4	565	851.7	784.4	527.2	263.5	130.8	85.4	174.4	129	122.8	115.1	113	104.6	57.1	26.8	21.8	23.3
income-statement-row.row.cost-and-expenses	3474.47	3441.6	2851.5	2929.8	2580.1	3563.6	3796.2	2844.9	1655.6	759.1	359.7	349.1	255.3	229.9	223.9	232.1	233.9	159.1	106.8	80.8	68.8
income-statement-row.row.interest-income	10.95	11.4	11.8	0.9	0.1	2	5	8.2	7.8	17.2	1.2	3.1	2.9	1.3	0.3	0	0.9	0	0.1	0.1	0
income-statement-row.row.interest-expense	127.56	120.6	142.6	230	136.6	344.6	344.2	207	23.1	45.1	23.8	14	5.4	2.2	1.5	0	1	1	1.6	1.3	0.8
income-statement-row.row.selling-and-marketing-expenses	202.79	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-42.81	-116.5	-170.6	-516.3	-188.1	-2557.8	-1376.1	-248.6	-58.1	-22.1	-35.6	-11.3	3.3	5.6	2.2	3.1	2	1.3	-0.6	0.8	-1.4
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	-12.31	-0.4	318.1	322.5	258.5	384.4	-37	7.1	32.7	72.8	32.2	3.7	11.6	9.8	6.4	3.4	7.5	2	3	2.7	0.1
income-statement-row.row.total-operating-expenses	-42.81	-116.5	-170.6	-516.3	-188.1	-2557.8	-1376.1	-248.6	-58.1	-22.1	-35.6	-11.3	3.3	5.6	2.2	3.1	2	1.3	-0.6	0.8	-1.4
income-statement-row.row.interest-expense	127.56	120.6	142.6	230	136.6	344.6	344.2	207	23.1	45.1	23.8	14	5.4	2.2	1.5	0	1	1	1.6	1.3	0.8
income-statement-row.row.depreciation-and-amortization	200.83	238.7	166.5	163.3	170.7	-345.8	230.4	197.7	100.9	69.5	40.7	40.2	28.6	21.3	16.4	6.7	5.2	4.1	4.1	4	4
income-statement-row.row.ebitda-caps	258.8	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	57.97	126.8	358	153.9	198.1	120.8	-1296.9	298.7	430	328.1	282.1	201	76.5	74.4	72.8	53.2	45.8	37.8	21.3	18.8	13.7
income-statement-row.row.income-before-tax	15.16	10.3	187.5	-362.4	10	-2437	-1333.9	305.8	461.6	400.5	290.3	204.3	85	83	77.6	56.2	53.1	40.4	22.7	20.2	13.7
income-statement-row.row.income-tax-expense	-26.88	-28.7	23.2	4.9	52.5	60.5	53.8	83.1	65.4	78.4	33.2	33	12.1	11.6	11.7	8.4	8.6	6.6	3.4	2.6	0.7
income-statement-row.row.net-income	33.61	30.8	156.1	-367.3	-42.5	-2497.5	-1417.8	202.8	403.6	323.6	257.3	169.8	73.7	71.3	66	47.8	44.5	33.8	19.3	17.6	13.7